Fortis Frontier PLC
("Fortis Frontier" or the “Company")
Cancellation of admission to trading on AIM
Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell, announces the cancellation from trading in the Company’s ordinary shares on AIM with effect from 7.00 a.m. on 12 November 2026, as it has been unable to acquire another company or business by way of a reverse takeover in accordance with AIM Rule 41.
As previously reported, the Board is currently evaluating some interesting opportunities which it believes could add value for shareholders. In addition, the Directors will also carefully consider how to provide an orderly market for shareholders in its ordinary shares in the future.
For further information contact:
Fortis Frontier PLC | |
Adam Reynolds, Executive Chairman | via Walbrook PR |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 |
Neil Baldwin / Dillon Wall | |
Singer Capital Markets (Broker) | Tel: +44 (0)20 7496 3000 |
Russell Cook / Amber Higgs | |
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44(0)7407 804 654 |
About Fortis Frontier PLC
On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.